Drug retention rate and predictive factors of drug survival for secukinumab in radiographic axial spondyloarthritis-Reference-Cited by-同舟云学术

Drug retention rate and predictive factors of drug survival for secukinumab in radiographic axial spondyloarthritis

Published:2022-09-21 Issue:1 Volume:43 Page:147-156
ISSN:1437-160X
Container-title:Rheumatology International
language:en
Short-container-title:Rheumatol Int

Author:

Armağan Berkan^ORCID,Kılıç Levent^ORCID,Farisoğulları Bayram^ORCID,Yardımcı Gözde Kübra^ORCID,Bilgin Emre^ORCID,Bölek Ertuğrul Çağrı^ORCID,Karadağ Ömer^ORCID,Bilgen Şule Apraş^ORCID,Kiraz Sedat^ORCID,Ertenli İhsan^ORCID,Kalyoncu Umut^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s00296-022-05213-1.pdf

Reference39 articles.

1. Taurog JD, Chhabra A, Colbert RA (2016) Ankylosing spondylitis and axial spondyloarthritis. N Engl J Med 374(26):2563–2574. https://doi.org/10.1056/NEJMra1406182

2. van der Heijde D, Ramiro S, Landewe R, Baraliakos X, Van den Bosch F, Sepriano A et al (2017) 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis 76(6):978–991. https://doi.org/10.1136/annrheumdis-2016-210770

3. Ward MM, Deodhar A, Gensler LS, Dubreuil M, Yu D, Khan MA et al (2019) 2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis. Arthritis Rheumatol 71(10):1599–1613. https://doi.org/10.1002/art.41042

4. Braun J, Baraliakos X, Kiltz U (2016) Secukinumab (AIN457) in the treatment of ankylosing spondylitis. Expert Opin Biol Ther 6(5):711–722. https://doi.org/10.1517/14712598.2016.1167183

5. Duarte JH (2016) Spondyloarthropathies: IL-17A blockade ameliorates ankylosing spondylitis. Nat Rev Rheumatol 12(2):72. https://doi.org/10.1038/nrrheum.2016.7

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritis;Frontiers in Immunology;2024-07-15

2. Weight loss affects disease activity and treatment response in inflammatory rheumatic diseases;Joint Bone Spine;2024-05

3. Real-world experience of IL-17Ai drug survival in a large cohort of axial spondyloarthritis and psoriatic arthritis;Rheumatology Advances in Practice;2023-12-09

4. Effect of body mass index on treatment response of biologic/targeted-synthetic DMARDs in patients with rheumatoid arthritis, psoriatic arthritis or axial spondyloarthritis. A systematic review;Autoimmunity Reviews;2023-07

5. Does obesity affect treatment response to secukinumab and survival in ankylosing spondylitis? Real-life data from the TURKBIO Registry;Modern Rheumatology;2023-06-22